Account
Case Studies
26.04.2023
Undertaking a NICE advice procedure

Our client had concerns as to whether the clinical end-points in their phase III trial were relevant...

Read more
Case Studies
26.04.2023
Optimising trial design through the EUnetHTA

Our clients have been developing new drugs for crowded, rapidly evolving therapy areas, with uncerta...

Read more
Case Studies
26.04.2023
Obtaining payer scientific advice

Our client was seeking to launch and in-licensed product in the EU, following launch in the US.

Read more
Case Studies
26.04.2023
Optimising a phase III trial design

Our client wanted to organise an advisory board to seek guidance from a range of stakeholders within...

Read more
Case Studies
26.04.2023
Development of an EU P&R strategy

Our client needed to understand the clinical and economic evidence requirements that drive payer dec...

Read more
Case Studies
26.04.2023
Our client wanted to gain an understanding

Our client wanted to gain an understanding of payer willingness to pay and determine the likely clin...

Read more
Case Studies
26.04.2023
Gaining payer insights

Our client wanted to understand the clinical and economic evidence requirements that drive payer dec...

Read more
Case Studies
26.04.2023
Gaining payer insights

Our client required focused payer value messages for their orphan drug as payers were not recognizin...

Read more
Case Studies
26.04.2023
Biosimilar country pricing and market access

Our client wanted to gain a better understanding of current and forthcoming policy measures affectin...

Read more
Case Studies
26.04.2023
Partnered with a biosimilar company

Development and submission of payer communication materials and pricing and reimbursement dossiers f...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.